Medical Oncologist
Department of General Medical Oncology, University Hospitals Leuven, and Laboratory of Experimental Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium, Belgium
Patrick Schöffski is a German medical doctor specializing in internal medicine, hematology and medical oncology.
Schöffski's main clinical interest is the treatment of solid tumors and lymphomas. He is involved in prospective clinical trials (Phase I-III) in various tumor types, with a focus on orphan malignancies. He leads an active phase I trial team in Leuven and has a strong interest in multitumor phase II-screening studies. He has been involved in registration trials of antineoplastic agents in a variety of solid tumors with significant activity in rare malignancies and sarcoma.
His research group at the Laboratory of Experimental Oncology of KU Leuven concentrates on mesenchymal malignancies and developed more than 70 patient-derived xenograft models of soft tissue sarcomas and gastrointestinal stromal tumors since 2004. Furthermore, the lab developed readily available tissue microarrays, blood collections and clinical databases related to various types of sarcoma. Schöffski's translational work forms the basis for multiple Master-, Doctoral and PhD thesis projects in his group.
Schöffski has published more than 380 papers. He has been an independent advisor to Cancéropôle Île-de-France, Paris (France), the Ontario Institute for Cancer Research, Toronto (Canada), the Comprehensive Cancer Center of Helsinki University Hospital (Finland) and the Belgian Nuclear Research Centre, Brussels/Mol (Belgium). He consults for a number of pharmaceutical companies, biotech companies, academic institutions and venture capital groups investing in oncology assets through his own consulting firm CADEAU BV in Belgium. His strong clinical and trial methodology background is the basis for various independent data monitoring activities for early and late stage clinical trials in oncology and related disciplines.
